Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Public Health|December 9, 2022
Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in FranceChristine Rousset-Jablonski, Faustine Dalon, Quitterie Reynaud, et al.
BMC Pulmonary Medicine|May 3, 2015
Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data studyManon Belhassen, Gérard de Pouvourville, Laurent Laforest, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 16, 2016
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohortCaroline Papeix, Sandra Vukusic, Romain Casey, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2019
Effects of short- and long-acting beta-agonists on asthma exacerbations: a prospective cohortEric Van Ganse, Nathalie Texier, Alexandra L Dima, et al.
Medicine|April 16, 2016
Recurrent Wheezing in Infants: A Population-Based StudyManon Belhassen, Jacques De Blic, Laurent Laforest, et al.
Plos One|August 24, 2018
Impact of asthma on women and men: Comparison with the general population using the EQ-5D-5L questionnaireGimena Hernandez, Alexandra L Dima, Àngels Pont, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2016
What We Mean When We Talk About Adherence in Respiratory MedicineBernard Vrijens, Alexandra L Dima, Eric Van Ganse, et al.
Clinical Cardiology|July 18, 2019
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non-valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM studyFabien Picard, Eric Van Ganse, Gregory Ducrocq, et al.
Journal of Medical Internet Research|January 24, 2019
EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional StudyGimena Hernandez, Olatz Garin, Alexandra L Dima, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 28, 2022
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in FranceManon Belhassen, Olivier Hanon, Philippe Gabriel Steg, et al.
Pageof 11